Latest Articles
Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models - Frontiers
Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models Frontiers
Published: Nov. 11, 2025, 4:15 p.m.
Early-onset uterine cancer research seeks new therapy development for younger patients - Today@Wayne
Early-onset uterine cancer research seeks new therapy development for younger patients Today@Wayne
Published: Oct. 6, 2025, 4:10 p.m.
The role of dysbiosis in shaping host immunity in endometrial cancer development - Frontiers
The role of dysbiosis in shaping host immunity in endometrial cancer development Frontiers
Published: Aug. 11, 2025, 9:50 a.m.
HOXB13 in cancer development: molecular mechanisms and clinical implications - EurekAlert!
HOXB13 in cancer development: molecular mechanisms and clinical implications EurekAlert!
Published: Aug. 6, 2025, 3:41 a.m.
Gates Foundation To Invest $2.5b On Women’s Health Research, Development - Channels Television
Gates Foundation To Invest $2.5b On Women’s Health Research, Development Channels Television
Published: Aug. 5, 2025, 10:38 a.m.
UN Sustainable Development Goals Archives - Pharmafile
UN Sustainable Development Goals Archives Pharmafile
Published: July 29, 2025, 9:20 a.m.
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Insider Monkey
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Insider Monkey
Published: July 10, 2025, 3:21 p.m.
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Yahoo
Published: July 10, 2025, 3:13 p.m.
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure - geneonline.com
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure geneonline.com
Published: July 10, 2025, 8:10 a.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MSN
Organon to halt development of endometriosis pain drug after mid-stage trial failure MSN
Published: July 3, 2025, 10:49 p.m.
Link copied to clipboard!